-
These two countries supply 81% of the world's lithium production capacity
Time of Update: 2023-01-06
, has publicly called for greater investment in lithium mining to close what he sees as a huge gap between supply and demand due to the adoption of electric vehicles.
-
These two countries supply 81% of the world's lithium production capacity
Time of Update: 2023-01-06
, has publicly called for greater investment in lithium mining to close what he sees as a huge gap between supply and demand due to the adoption of electric vehicles.
-
Domestic pharmaceutical equipment breaks the situation and moves forward, and the future market growth can be expected
Time of Update: 2023-01-04
Compared with the past, domestic pharmaceutical machinery enterprises in recent years through continuous strengthening of technical research and continuous increase in research and development investment, some equipment performance has been comparable to imported equipment, coupled with domestic pharmaceutical machinery enterprises have the advantages of fast delivery, high after-sales service level, including Chutian Technology, Dongfulong and other head enterprises are actively embracing new opportunities, orders have increased significantly.
-
Bloomberg: Global investment in renewable energy capacity will reach $300 billion in 2020
Time of Update: 2023-01-02
BNEF expects global investment in renewable energy capacity to increase again in 2020, reaching an estimated $300 billion.
BNEF expects global investment in renewable energy capacity to increase again in 2020, reaching an estimated $300 billion.
-
Africa's mini-grid sector will usher in rapid development
Time of Update: 2022-12-28
Africa's mini-grid sector will usher in rapid development Launched in April this year, one of the main points on AMDA's agenda is working with donors, governments and other stakeholders to develop a results-based financing (RBF) fund to help microgrids scale.
-
Climate finance for the world's six largest multilateral development banks reached US$35.2 billion in 2017
Time of Update: 2022-12-27
4 billion, or 21 percent of the 2017 total, was used to finance climate adaptation projects in emerging and developing countries to help economies cope with the effects of climate change, such as abnormal rainfall, drought and worsening extreme weather events.
-
Siemens Gamesa Renewable Energy becomes a new member of GCX
Time of Update: 2022-12-26
”(This article first published cable network: /, please indicate the source for reprinting)/ It is understood that the index includes companies that actively guide their responsibilities and contribute substantially to addressing the global commitments and challenges of the millennium: climate change, poverty, access to water, deforestation, biodiversity, population growth and good governance.
-
The main force of Shanghai copper rises first and then suppresses fundamental support still needs attention
Time of Update: 2022-12-24
On the whole, currently affected by the epidemic, the pattern of weak supply and demand is obvious, but the market sentiment is relatively obvious.
On the whole, currently affected by the epidemic, the pattern of weak supply and demand is obvious, but the market sentiment is relatively obvious.
-
Issue 1 2017 - BASF completes acquisition of Chemetall
Time of Update: 2022-11-11
BASF and Chemetall are global market leaders, and by combining the expertise and innovation of both companies, we will accelerate innovation and help our customers be more successful.
-
AI pharmaceuticals have greatly shortened the R&D time, and more than 60 local AI pharmaceutical companies have entered the market
Time of Update: 2022-10-20
With the rapid development of AI technology and the continuous expansion and maturity of application scenarios, AI technology is gradually penetrating into the field of biopharmaceuticals, which is expected to change the problems of long R&D time, high cost, low efficiency and high risk of traditional pharmaceuticals, and bring major changes to the new drug industry.
-
SilkAir acquires Polish BOPP film company to provide new capabilities for label sector materials
Time of Update: 2022-08-22
The company's customers are exclusively flexible packaging companies As one of the largest manufacturers of polypropylene products in Poland, Flexpol's sales revenue in 2019 was about 70 million US dollars, and its adjusted EBITDA was about 3.
-
Inner Mongolia 2021 Top Ten Economic Figures Announced Professor Zhang Heping won the Innovation Special Contribution Award
Time of Update: 2022-05-08
Along the way, Professor Zhang Heping has made great contributions to the discovery, preservation and related clinical research of probiotic strains in China .
Along the way, Professor Zhang Heping has made great contributions to the discovery, preservation and related clinical research of probiotic strains in China .
-
Deepen the reform of "delegation, management and service" to stimulate the vitality of chemical enterprises
Time of Update: 2022-03-20
" Many chemical companies believe that the "Plan" emphasizes administrative decentralization, simplification of procedures, reduction of time limits, and reduction of free fees, and has issued implementation rules, which will create a legal, international, service-oriented, and convenient business environment, and stimulate The vitality of the main body of the chemical market and the endogenous driving force for the development of the industry.
-
Asia-Pacific Phase III BHV3000-310 Study Shows Oral Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonist Provides Rapid and Durable Migraine Relief
Time of Update: 2022-03-02
Led by BioShin , the Phase 3 regional multicenter study BHV3000-310 met its co-primary endpoints evaluating the efficacy and safety of the oral calcitonin gene-related peptide ( CGRP ) receptor antagonist rimegepant orally disintegrating tablet ( ODT ) .
-
Yang Liang, Vice President of Luye Pharma Investment: The Group will usher in a critical turning point
Time of Update: 2022-02-23
In the past few years, the promotion of some international projects has helped us to better familiarize ourselves with and adapt to different international market environments, so that the operation of our international system has become more mature and efficient, and we have formed a relatively advantageous international R&D, registered clinical , supply chain and commercialization capabilities, which have laid a very solid foundation for the launch of new products in the future .
